Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
Glioblastoma (GBM) is one of the leading lethal tumors, featuring aggressive malignancy and poor outcome to current standard temozolomide (TMZ) or radio-based therapy. Developing immunotherapies, especially immune checkpoint inhibitors, have improved patient outcomes in other solid tumors but remain...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2022-08-01
|
| Seri Bilgileri: | Life |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2075-1729/12/8/1225 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|